Co-Authors
This is a "connection" page, showing publications co-authored by Florian Klein and Veronica Di Cristanziano.
Connection Strength
1.603
-
Kinetics and correlates of the neutralizing antibody response to SARS-CoV-2 infection in humans. Cell Host Microbe. 2021 06 09; 29(6):917-929.e4.
Score: 0.236
-
Evaluation of a New Spike (S)-Protein-Based Commercial Immunoassay for the Detection of Anti-SARS-CoV-2 IgG. Microorganisms. 2021 Mar 31; 9(4).
Score: 0.234
-
Detection of SARS-CoV-2 viremia before onset of COVID-19 symptoms in an allo-transplanted patient with acute leukemia. Bone Marrow Transplant. 2021 03; 56(3):716-719.
Score: 0.226
-
RNAemia Corresponds to Disease Severity and Antibody Response in Hospitalized COVID-19 Patients. Viruses. 2020 09 18; 12(9).
Score: 0.226
-
Longitudinal Isolation of Potent Near-Germline SARS-CoV-2-Neutralizing Antibodies from COVID-19 Patients. Cell. 2020 09 17; 182(6):1663-1673.
Score: 0.226
-
Longitudinal Isolation of Potent Near-Germline SARS-CoV-2-Neutralizing Antibodies from COVID-19 Patients. Cell. 2020 08 20; 182(4):843-854.e12.
Score: 0.223
-
Post-COVID syndrome in non-hospitalised patients with COVID-19: a longitudinal prospective cohort study. Lancet Reg Health Eur. 2021 Jul; 6:100122.
Score: 0.059
-
First manifestation of adult-onset Still's disease after COVID-19. Lancet Rheumatol. 2021 May; 3(5):e319-e321.
Score: 0.059
-
Sensitivity of anti-SARS-CoV-2 serological assays in a high-prevalence setting. Eur J Clin Microbiol Infect Dis. 2021 May; 40(5):1063-1071.
Score: 0.058
-
Rapid SARS-CoV-2 testing in primary material based on a novel multiplex RT-LAMP assay. PLoS One. 2020; 15(11):e0238612.
Score: 0.057